[New antidepressive agents].
LaBranche
S
S
Centre hospitalier Anna-Laberge, Châteauguay.
D015057:1-Naphthylamine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology; D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D001549:Benzamides / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D002648:Child; D004347:Drug Interactions; D005473:Fluoxetine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D016666:Fluvoxamine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D006801:Humans; D020912:Moclobemide; D017374:Paroxetine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D020280:Sertraline
D015057:1-Naphthylamine; D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D018687:Antidepressive Agents, Second-Generation; D001549:Benzamides; D005473:Fluoxetine; D016666:Fluvoxamine; D020912:Moclobemide; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline
Les nouveaux antidépresseurs.